Alcon Launches Chewable AREDS2 Eye Vitamin

 Alcon Launches Chewable AREDS2 Eye Vitamin

Alcon recently launched SYSTANE® ICAPS® Chewable AREDS2 Eye Vitamin in the U.S market to help support eye health in people with intermediate to advanced Age-Related Macular Degeneration (AMD).

According to Alcon, the SYSTANE ICAPS Chewable AREDS2 is the first chewable vitamin formulation in the U.S. based on the Age-Related Eye Disease Study 2 (AREDS2) study. The new vitamin is reportedly formulated with six clinically-proven nutrients based on clinical evidence from AREDS2, including vitamins C and E, zinc, copper, lutein and zeaxanthin. And its formulations reportedly have lower zinc levels and no beta-carotene compared to formulations based on the original AREDS study.

SYSTANE ICAPS Chewable AREDS2 Eye Vitamin will reportedly be available in retail stores by June 1st. 

Like what you read? Follow OptometryWeb to keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Click here to read the full press release

Source: Alcon

  • <<
  • >>

Comments